Do you want to read an article? Please log in or register.
Management of ARDS and Refractory Hypoxemia: A Multicenter Observational Study
Related content
RECOMMENDED
ARDS
Prevalence of Reverse Triggering in Early ARDS: Results from a Multicenter Observational Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Rodriguez PO, Tiribelli N, Fredes S, Gogniat E, Plotnikow G, Ceballos IF, Pratto R, Raimondi A, Guaymas M, Ilutovich S, San Roman E, Madorno M, Maskin P, Brochard L, Setten M, GRAAVEplus (Grupo Argentino de estudio de Asincronías en la VEntilación mecánica) study group.
doi: 10.1016/j.chest.2020.08.018.
Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials
Respir Care.
Pais FM, Sinha P, Liu KD, Matthay MA
doi: 10.4187/respcare.06034.
RECOMMENDED
Further Publications
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG, Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium).
doi: 10.1016/S2213-2600(21)00004-7
RECOMMENDED
ARDS
Mechanical Ventilation Management during ECMO for ARDS: An International Multicenter Prospective Cohort
Am J Respir Crit Care Med.
Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, Pellegrino V, Vuylsteke A, Guervilly C, McGuinness S, Pierard S, Breeding J, Stewart C, Ching SSW, Camuso JM, Stephens RS, King B, Herr D, Schultz MJ, Neuville M, Zogheib E, Mira JP, Rozé H, Pierrot M, Tobin A, Hodgson C, Chevret S, Brodie D, Combes A, International ECMO Network (ECMONet), and the LIFEGARDS Study Group.
doi: 10.1164/rccm.201806-1094OC.
RECOMMENDED
ARDS
Patterns and impact of arterial CO2 management in patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Madotto F, Rezoagli E, McNicholas BA, Pham T, Slutsky AS, Bellani G, Laffey JG, LUNG SAFE Investigators and the ESICM Trials Group.
doi: 10.1016/j.chest.2020.05.605.
How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
Ann Intensive Care.
Hraiech S, Forel JM, Guervilly C, Rambaud R, Lehingue S, Adda M, Sylla P, Valera S, Carvelli J, Gainnier M, Papazian L, Bourenne J
doi: 10.1186/s13613-017-0305-2.
ARDS
Epidemiology, Mechanical Power, and 3-Year Outcomes in ARDS Patients Using Standardized Screening: An Observational Cohort Study
Ann Am Thorac Soc.
Parhar KKS, Zjadewicz K, Soo A, Sutton A, Zjadewicz M, Doig L, Lam C, Ferland A, Niven DJ, Fiest K, Stelfox HT, Doig CJ
doi: 10.1513/AnnalsATS.
ARDS
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X
doi: 10.1186/s13054-021-03594-6
RECOMMENDED
ARDS
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X
doi: 10.1186/s13054-021-03594-6